Stress cardiomyopathies beyond Takotsubo: does a common catecholaminergic pathophysiology fit all?

Giuseppe Andò1, Ilaria Boretti, Roberta Tripodi

  • 1Department of Clinical and Experimental Medicine, Cardiology Section, Policlinico "G. Martino", University of Messina, Messina, Italy.

Insights

Diagnostic criteria for Takotsubo cardiomyopathy (TTC) need widening due to similarities with cardiac dysfunction after cerebrovascular events. A catecholamine surge may unify these conditions, suggesting new terms like "acute ballooning cardiomyopathy".

Area of Science:

  • Cardiology
  • Neurology
  • Endocrinology

Background:

  • Current diagnostic criteria for Takotsubo cardiomyopathy (TTC) are debated.
  • Cardiac dysfunction following cerebrovascular events shares similarities with typical TTC.
  • Existing research highlights clinical, histological, and scintigraphic overlaps between TTC and other Takotsubo-like syndromes.

Discussion:

  • A central catecholamine surge is hypothesized to trigger left ventricular contraction abnormalities in these related conditions.
  • Overlapping features suggest a need to broaden the definition of Takotsubo cardiomyopathy.
  • The current diagnostic framework may not fully encompass the spectrum of catecholamine-mediated cardiac dysfunction.

Key Insights:

  • Widening TTC diagnostic criteria is proposed based on observed similarities with neurogenic cardiac dysfunction.
  • A unifying hypothesis centers on catecholamine surge as the common pathophysiological mechanism.
  • Similarities suggest a spectrum of disease rather than distinct entities.

Outlook:

  • Future research should explore the proposed unifying hypothesis of catecholamine surge.
  • Consideration of alternative nomenclature, such as 'acute ballooning cardiomyopathy' or 'catecholamine-induced stress cardiomyopathy', is recommended.
  • Refining diagnostic criteria could improve patient identification and management for stress-related cardiomyopathies.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
2.2K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K